|
US4076823A
(en)
*
|
1977-08-18 |
1978-02-28 |
E. R. Squibb & Sons, Inc. |
Triazolo-2,4-benzodiazepines
|
|
US5683998A
(en)
*
|
1991-04-23 |
1997-11-04 |
Toray Industries, Inc. |
Tricyclic triazolo derivatives, processes for producing the same and the uses of the same
|
|
AU654548B2
(en)
*
|
1991-04-23 |
1994-11-10 |
Toray Industries, Inc. |
Tricyclic triazole derivative, production thereof, and use thereof
|
|
FR2769309B1
(fr)
|
1997-10-08 |
2001-06-15 |
Oreal |
Composition de teinture d'oxydation des fibres keratiniques comprenant un derive d'aminoacide en tant que base d'oxydation et nouveaux derives d'aminoacides
|
|
US20030119029A1
(en)
*
|
1999-04-30 |
2003-06-26 |
Regents Of The University Of Michigan |
Compositions and methods relating to novel benzodiazepine compounds and targets thereof
|
|
US20060025388A1
(en)
|
1999-04-30 |
2006-02-02 |
Glick Gary D |
Compositions and methods relating to novel compounds and targets thereof
|
|
US20050113460A1
(en)
*
|
1999-04-30 |
2005-05-26 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
|
EP2359831A3
(en)
|
1999-04-30 |
2012-02-01 |
The Regents of the University of Michigan |
Therapeutic applications of pro-apoptotic benzodiazepines
|
|
US7276348B2
(en)
*
|
1999-04-30 |
2007-10-02 |
Regents Of The University Of Michigan |
Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof
|
|
US20040176358A1
(en)
*
|
1999-04-30 |
2004-09-09 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
|
US7144880B2
(en)
|
1999-04-30 |
2006-12-05 |
Regents Of The University Of Michigan |
Compositions relating to novel compounds and targets thereof
|
|
US20050272723A1
(en)
*
|
2004-04-27 |
2005-12-08 |
The Regents Of The University Of Michigan |
Methods and compositions for treating diseases and conditions associated with mitochondrial function
|
|
US20060052369A1
(en)
*
|
2004-09-07 |
2006-03-09 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
|
US7638624B2
(en)
*
|
2005-01-03 |
2009-12-29 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel benzodiazepine compounds and derivatives
|
|
CA2611031A1
(en)
|
2005-06-01 |
2007-05-10 |
The Regents Of The University Of Michigan |
Unsolvated benzodiazepine compositions and methods
|
|
US20070105844A1
(en)
*
|
2005-10-26 |
2007-05-10 |
Regents Of The University Of Michigan |
Therapeutic compositions and methods
|
|
CA2779041A1
(en)
|
2005-11-01 |
2007-05-10 |
The Regents Of The University Of Michigan |
Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties
|
|
DE102005061840A1
(de)
|
2005-12-23 |
2007-06-28 |
Merck Patent Gmbh |
Triazolderivate
|
|
US7759338B2
(en)
*
|
2006-04-27 |
2010-07-20 |
The Regents Of The University Of Michigan |
Soluble 1,4 benzodiazepine compounds and stable salts thereof
|
|
JP5264716B2
(ja)
|
2006-06-09 |
2013-08-14 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
化合物およびその標的に関連する組成物および方法
|
|
JP5383513B2
(ja)
|
2007-03-09 |
2014-01-08 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
化合物およびその標的に関連する組成物ならびに方法
|
|
MX2010002732A
(es)
|
2007-09-14 |
2010-06-02 |
Univ Michigan |
Inhibidores de f1f0-atpasa y metodos relacionados.
|
|
AU2008323945B2
(en)
|
2007-11-06 |
2013-11-28 |
The Regents Of The University Of Michigan |
Benzodiazepinone compounds useful in the treatment of skin conditions
|
|
JP5567573B2
(ja)
|
2008-09-11 |
2014-08-06 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
アリールグアニジンｆ１ｆ０−ａｔｐアーゼ阻害剤およびそれと関連する方法
|
|
US8604023B2
(en)
|
2009-04-17 |
2013-12-10 |
The Regents Of The University Of Michigan |
1,4-benzodiazepinone compounds and their use in treating cancer
|
|
EP2470020A4
(en)
|
2009-09-18 |
2013-03-13 |
Univ Michigan |
BENZODIAZEPINONE COMPOUNDS AND TREATMENT METHODS THEREWITH
|
|
WO2011062766A2
(en)
|
2009-11-17 |
2011-05-26 |
The Regents Of The University Of Michigan |
1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
|
|
WO2011062765A2
(en)
|
2009-11-17 |
2011-05-26 |
The Regents Of The University Of Michigan |
1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
|
|
US9249161B2
(en)
|
2010-12-02 |
2016-02-02 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
AR084070A1
(es)
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
|
EP2705039B1
(en)
*
|
2011-05-04 |
2017-07-26 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
US9328117B2
(en)
|
2011-06-17 |
2016-05-03 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
US9624244B2
(en)
|
2012-06-06 |
2017-04-18 |
Constellation Pharmaceuticals, Inc. |
Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof
|
|
TWI602820B
(zh)
|
2012-06-06 |
2017-10-21 |
星宿藥物公司 |
溴域抑制劑及其用途
|
|
CA2952830C
(en)
|
2014-06-20 |
2022-11-01 |
Constellation Pharmaceuticals, Inc. |
Crystalline forms of 2-((4s)-6-(4-chlorophenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide
|